ADHD Diagnosis Trends: Why Adult Cases Surged After COVID

Adult ADHD diagnoses rose sharply during and after the COVID-19 pandemic across multiple countries. The increase does not mean COVID caused ADHD. Rather, pandemic-era disruptions stripped away the routines and coping structures that had kept existing symptoms manageable for many adults, pushing them toward evaluation for the first time.

What do the numbers actually show?

CDC data collected in late 2023 estimates that 15.5 million US adults (6.0%) had a current ADHD diagnosis, roughly one in 16 adults. Approximately half of those adults received their diagnosis at age 18 or older [1]. That figure represents a substantial increase from pre-pandemic estimates, which placed adult ADHD prevalence closer to 4.4%.

The trend is not limited to the United States. A population-based study covering all of British Columbia (2013 to 2023) found that newly diagnosed adult ADHD averaged 8.8 cases per 100,000 population monthly before the pandemic. During the pandemic (March 2020 to June 2021), that rate rose to 19.2, driven by a 4.9% month-over-month increase. After the provincial state of emergency ended in July 2021, the monthly rate jumped by 107.3% and continued growing, averaging 34.8 cases per 100,000 in the post-pandemic period (Hu et al., 2025) [2].

In Finland, a nationwide cohort study of 5.6 million people found that new ADHD diagnoses doubled during the pandemic, from 238 per 100,000 in 2020 to 477 per 100,000 in 2022. The sharpest increases appeared among young women aged 13 to 20 (a 2.6-fold increase) and women aged 21 to 30 (a 3.0-fold increase) (Auro et al., 2024) [3].

A Korean study analyzing national insurance claims data for over 1.7 million individuals (ages 6 to 29) found that ADHD incidence more than doubled during the pandemic period compared to pre-pandemic years (Song et al., 2025) [4].

These are not small fluctuations. Multiple countries, using different healthcare systems and data sources, recorded the same basic pattern: a sharp and sustained rise in ADHD diagnoses among adults during and after the pandemic.

What was happening before the pandemic?

ADHD diagnosis rates among adults were already climbing before 2020, though the pace varied by country and age group. In Finland, lifetime ADHD prevalence rose from 1.02% in 2015 to 1.80% in 2020, a steady increase that predated the pandemic by years (Auro et al., 2024) [3]. In British Columbia, the pre-pandemic trend showed a gradual upward slope from 2013 onward (Hu et al., 2025) [2].

Several factors contributed to this pre-existing trend. Clinical guidelines increasingly recognized that ADHD persists into adulthood for many people, shifting the condition's profile away from the childhood-only stereotype. Growing public awareness, partly driven by online communities and advocacy organizations, encouraged adults to seek evaluation. And diagnostic criteria in the DSM-5 (published in 2013) lowered the symptom threshold for adults from six to five symptoms, reflecting research showing that adults can experience significant impairment at lower symptom counts.

So the pandemic did not create the trend from nothing. It accelerated a trajectory that was already underway. Understanding this matters for interpreting the post-2020 data: the surge built on a foundation of gradually improving recognition. If you are exploring whether ADHD symptoms may apply to your experience, this context helps explain why so many adults are being identified now rather than in childhood.

How did the pandemic accelerate diagnoses?

Pandemic disruptions removed the external routines that had quietly compensated for undiagnosed ADHD in many adults.

The pandemic created a set of conditions that made ADHD symptoms both more visible and harder to manage. Three mechanisms stand out.

Routine collapse. Adults with undiagnosed ADHD often rely on external structure (commutes, office environments, in-person meetings, social schedules) to compensate for difficulties with self-regulation and time management. Remote work and lockdowns removed those scaffolds simultaneously. Tasks that had been manageable in a structured office became overwhelming at home, where distractions were constant and the boundary between work and rest dissolved. For many adults, this was the first time their attention difficulties felt unmanageable.

Increased emotional and cognitive load. A meta-analysis of 18 studies (6,491 participants across 10 countries) found that many individuals and their caregivers reported an increase in ADHD symptoms during the pandemic (Rogers et al., 2023) [5]. While this meta-analysis focused primarily on children, the underlying mechanism applies broadly: pandemic-era stress, uncertainty, and disrupted sleep patterns can worsen attention and impulse control in people whose neurology already makes these functions more effortful.

Telehealth expansion. Before 2020, getting an ADHD evaluation typically meant finding a specialist, traveling to an office, and sitting through in-person appointments during business hours. The pandemic forced a rapid expansion of telehealth services, and regulatory changes in many countries made remote psychiatric evaluation legal and reimbursable for the first time. CDC data from 2023 shows that approximately half of US adults with ADHD had used telehealth for ADHD services [1]. This removed geographic barriers and made evaluation accessible to adults who could not take time off work or who lived far from specialists.

A Canadian primary care study found that while the number of patients presenting for ADHD-related visits during the pandemic was consistent with pre-pandemic trends, the frequency of visits per patient in 2021 was 1.32 times higher than expected, suggesting that patients who were already in the system sought care more intensively (Butt et al., 2023) [7].

Why did so many adults recognize ADHD symptoms during this period?

Beyond the structural factors, a cultural shift in ADHD awareness played a significant role. Social media platforms, particularly TikTok and Instagram, saw an explosion of ADHD-related content during lockdowns. Adults scrolling through descriptions of executive dysfunction, time blindness, and emotional dysregulation recognized their own experiences, sometimes for the first time.

This is a genuinely double-edged phenomenon. On one side, social media reached people who had been struggling for years without a framework for understanding their difficulties. Many adults, particularly women and people of color who were historically underdiagnosed, found language for experiences they had never connected to a diagnosable condition. Research consistently shows that ADHD has been underdiagnosed in these groups, and increased awareness may be correcting a long-standing gap.

On the other side, short-form social media content can oversimplify. A 60-second video describing common ADHD traits may resonate with someone who has ADHD, but it may also resonate with someone experiencing burnout, anxiety, depression, or the cognitive effects of chronic stress. These conditions share overlapping symptoms (difficulty concentrating, forgetfulness, emotional reactivity), and self-identification based on social media content is not the same as clinical evaluation.

"ADHD is a neurodevelopmental disorder that develops during childhood and can last into adulthood." CDC MMWR, 2024 [1]

This distinction matters. ADHD is a neurodevelopmental condition with onset in childhood, even when it is first recognized in adulthood. A thorough evaluation looks at childhood history, rules out other explanations, and assesses functional impairment across settings. Social media awareness can be the starting point for that process, but it cannot replace it.

If you have been wondering whether your experiences align with ADHD, you can take a free ADHD screening questionnaire to organize your observations before speaking with a clinician.

Is this better recognition or overdiagnosis?

Social media and online content played a significant role in prompting adults to pursue formal ADHD evaluations.

This is the central debate in the field right now, and honest researchers acknowledge that both dynamics may be operating simultaneously. The question of whether ADHD is overdiagnosed does not have a simple answer.

The case for better recognition: Adult ADHD has been underdiagnosed for decades. Worldwide prevalence estimates of 2 to 5% among adults [1] suggest that millions of people have the condition without knowing it. Women, adults diagnosed with anxiety or depression first, and people without the hyperactive presentation have been systematically missed. The post-pandemic increase may represent these individuals finally reaching evaluation.

The case for diagnostic concern: The speed and scale of the increase raise legitimate questions. When diagnosis rates quadruple in a few years, as they did in some demographics in Finland [3], it is worth asking whether every new diagnosis reflects the same level of clinical rigor. Telehealth evaluations, while accessible, may sometimes be shorter or less thorough than in-person assessments. Some direct-to-consumer telehealth companies have faced scrutiny for brief evaluations that critics argue do not meet established diagnostic standards.

What the data suggest: The Finnish study found that ADHD medication use did not increase proportionally to diagnoses, with 61.4% of those diagnosed having purchased ADHD medication in 2022 compared to 63.8% in 2020 [3]. This gap could mean that some newly diagnosed individuals are managing without medication, or it could suggest that some diagnoses are not leading to treatment, which might indicate lower clinical certainty.

Checklist: questions to consider when evaluating ADHD trend data

• Does the study distinguish between new diagnoses and total prevalence?
• Does it account for pre-pandemic trends (was the rate already rising)?
• Does it separate age groups and genders (trends vary dramatically by demographic)?
• Does it use clinical records or self-report (each has different limitations)?
• Does it address whether diagnostic standards remained consistent across the study period?
• Does it consider telehealth as a variable (access changes can look like prevalence changes)?

The most balanced reading of the evidence is that the pandemic revealed a large population of adults who had ADHD all along and simultaneously created conditions where some people without ADHD might be misidentified. Both things can be true, and distinguishing between them requires careful individual evaluation.

What are the healthcare implications?

The surge in adult ADHD diagnoses has created practical challenges across healthcare systems. Three stand out.

Medication shortages. CDC data from 2023 found that approximately one third of adults with ADHD took a stimulant medication in the previous year. Among those, 71.5% reported difficulty filling their prescription because the medication was unavailable [1]. Increased demand, combined with DEA manufacturing quotas and supply chain disruptions, has created persistent shortages of common stimulant medications in the US.

Workforce capacity. Many countries lack enough psychiatrists, psychologists, and other clinicians trained in adult ADHD assessment to meet current demand. In the UK, NHS waiting lists for adult ADHD assessment can stretch beyond two years in some regions. In Canada, the British Columbia data showing a fourfold increase in monthly diagnoses [2] implies a corresponding increase in demand for follow-up care, medication management, and therapy.

Diagnostic infrastructure. The rapid shift to telehealth raised questions about quality. Some telehealth platforms use structured, evidence-based protocols that mirror in-person standards. Others offer abbreviated assessments. Clinicians and professional organizations are still developing consensus on what constitutes an adequate remote ADHD evaluation.

How should you approach evaluation now?

If you recognize ADHD patterns in your own life, the post-pandemic context does not change the basic steps. A structured evaluation with a qualified clinician remains the standard for diagnosis. What has changed is that more pathways to that evaluation now exist.

Start by documenting your specific difficulties. Note which symptoms you experience, how long they have been present (ADHD symptoms must have been present before age 12, even if they were not recognized), and how they affect your work, relationships, and daily functioning. Bring concrete examples rather than general impressions.

Consider whether other explanations might account for your symptoms. Chronic stress, sleep deprivation, anxiety, depression, and burnout can all produce attention and memory difficulties that overlap with ADHD. A thorough evaluation will consider these possibilities. This is not about gatekeeping; it is about making sure you get the right support for the right condition.

Questions to bring to an ADHD evaluation

• What did my teachers or parents notice about my attention and behavior in childhood?
• Have my concentration difficulties been present across different jobs, schools, and life stages, or did they start during a specific stressful period?
• Do I have a family history of ADHD or related conditions?
• What strategies have I been using to compensate, and when did they stop working?
• Could my symptoms be better explained by anxiety, depression, sleep problems, or another condition?

If you want to organize your observations before booking an appointment, you can try our online ADHD self-assessment. A screening tool does not diagnose, but it can help you articulate your concerns clearly when you meet with a clinician.

Infographic: key points about adhd diagnosis trends covid. Multiple converging factors, not a single cause, explain why adult ADHD diagnoses rose sharply after 2020.

Frequently asked questions

Did COVID-19 cause ADHD in adults?

No. ADHD is a neurodevelopmental condition that begins in childhood. The pandemic did not create new cases. It disrupted routines and coping strategies that had been masking existing ADHD in many adults, prompting them to seek evaluation. Some research also suggests that SARS-CoV-2 infection may be associated with increased ADHD incidence in younger populations (Song et al., 2025), but this is an emerging area of study, not an established causal link.

How much did adult ADHD diagnoses increase during the pandemic?

The increase varied by country and demographic. In Finland, new diagnoses doubled between 2020 and 2022 [3]. In British Columbia, monthly new adult diagnoses rose from 8.8 to 34.8 per 100,000 between the pre-pandemic and post-pandemic periods [2]. US data shows 6.0% of adults reporting a current diagnosis in 2023 [1], up from earlier estimates of roughly 4.4%.

Why were women disproportionately affected by the diagnosis surge?

Women have historically been underdiagnosed with ADHD because they are more likely to present with inattentive symptoms rather than hyperactivity. The Finnish data showed the sharpest increases among young women aged 13 to 30 [3]. Pandemic-era awareness campaigns and social media content specifically highlighted how ADHD presents differently in women, reaching a population that had been overlooked. Learn more about late diagnosis patterns.

Is telehealth a reliable way to get an ADHD diagnosis?

Telehealth can be reliable when the evaluation follows established diagnostic protocols, including a thorough clinical interview, childhood history review, and consideration of alternative explanations. CDC data shows that about half of US adults with ADHD have used telehealth for ADHD services [1]. The quality depends on the clinician and the platform, not the medium itself.

Are ADHD diagnosis rates still rising?

Available data through 2023 suggests the rates have not returned to pre-pandemic levels. The British Columbia study found that post-pandemic rates continued to grow at 1.5% per month after the initial surge [2]. Whether this represents continued catch-up of underdiagnosed adults or a new baseline remains an open question.

Could my pandemic-era attention problems be something other than ADHD?

Yes. Chronic stress, burnout, anxiety, depression, sleep deprivation, and grief can all produce concentration difficulties, forgetfulness, and emotional reactivity that look similar to ADHD. A thorough ADHD evaluation distinguishes between these possibilities by examining childhood history and ruling out other conditions.

Why are there stimulant medication shortages?

Increased diagnoses led to increased prescriptions, but stimulant manufacturing in the US is subject to DEA production quotas that are set based on prior-year usage. When demand rises faster than quotas adjust, shortages result. CDC data found that 71.5% of adults taking stimulant medication reported difficulty filling their prescription in 2023 [1].

How do I know if I should get evaluated?

Consider evaluation if you have experienced persistent difficulties with attention, organization, time management, or impulse control across multiple life settings (not just during a single stressful period), and if these difficulties have been present since childhood even if they were not recognized at the time. A screening tool can help you organize your observations before seeing a clinician.

Did the pandemic change how ADHD is diagnosed?

The core diagnostic criteria (DSM-5) did not change. What changed was access: telehealth made evaluation available to more people, and increased public awareness motivated more adults to seek assessment. Some clinicians and researchers have raised concerns about whether the speed of some telehealth evaluations matches the thoroughness of traditional in-person assessments.

Are the rising numbers a global trend or mainly a US phenomenon?

The trend is global. Studies from Finland [3], South Korea [4], Canada [2], and the US [1] all document significant increases. The consistency across different healthcare systems and cultures suggests that the drivers (routine disruption, telehealth expansion, increased awareness) operated broadly rather than being specific to one country's healthcare market.